“REAL-TIME DISCOVERY OF INHIBITORS AMONG BILLION COMPOUNDS FOR PREVIEW AND
Innovations in computational techniques have enabled us to advance interactive virtual screening
platforms to speed up the identification of small molecules to disrupt protein function. As a step towards addressing polypharmacology issues, we plan to apply our state-of-the-art methodologies to build efficient tools to perform compound-and-target centric virtual screening of human proteins to discover pre-clinical compounds for hard to treat diseases.
CO-I on the grant is Alexander Dömling (U. of Groningen)